Home

Samsara BioCapital reported a 56.5% stake in Kalaris Therapeutics KLRS · 12,954,081 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
56.5%
Last report
56.5% · filed 25/12/22
Shares held
12,954,081 sh
Class
Common Stock, $0.0001 par value per share
Event date
25/12/18
Filed
26/02/17

56.5% stake · +0.0pp from the last report

Stake
56.5%
Last report
56.5%
Since last report
+0.0pp

Kalaris Therapeutics trades, last 26 weeks

What else happened in Kalaris Therapeutics around then

Filed or reported within 30 days of the trade day · 25/11/18~01/17

Samsara BioCapital's other 5% stake reports

  • Samsara BioCapital

    5% stakePMV Pharmaceuticals

    9.9% stake

    Filed 09/15

  • Samsara BioCapital

    5% stakeEloxx Pharmaceuticals

    9.9% stake

    Filed 08/14

  • Samsara BioCapital

    5% stakeRani Therapeutics Holdings

    9.9% stake

    Filed 05/28

  • Samsara BioCapital

    5% stakeKalaris Therapeutics

    54.2% stake

    Filed 05/22

  • Samsara BioCapital

    5% stakeSutro Biopharma

    6.4% stake

    Filed 05/15

Samsara BioCapital reported a 56.5% stake in Kalaris Therapeutics KLRS · 12,954,081 sh · amendment | Whalegun